ReNerve Limited (ASX:RNV)
Australia flag Australia · Delayed Price · Currency is AUD
0.0900
+0.0010 (1.12%)
At close: Mar 26, 2026

Revenue by Segment

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Jun '25 Jun '24 Jun '23
Medical Devices For Damaged Peripheral Nerves
271.71K177.37K128.49K
Medical Devices For Damaged Peripheral Nerves Growth
53.18%38.04%-
Total
271.71K177.37K128.49K
Total Growth
53.18%38.04%-

Revenue by Geography

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Jun '25 Jun '24 Jun '23
New Zealand
738.00789.00-
New Zealand Growth
-6.46%--
United States
267.87K176.58K-
United States Growth
51.70%--
Hong Kong
3.10K--
Australia
--128.49K
Total
271.71K177.37K128.49K
Total Growth
53.18%38.04%-
Source: S&P Global Market Intelligence.